29 November 2017 | News
The Pune facility plays an increasingly strategic role for the company.
Image credit- datwyler.com
The Swiss-based leading industrial supplier, Datwyler, has announced that the expansion of its plant in Pune will be completed by end of 2017 and first samples will be supplied in July 2018. The company offers state-of-the-art solutions for drug packaging and medical devices.
The facility underlines the company’s commitment to India and acknowledges the country’s role in the global pharmaceutical market. The expanded facility will manufacture according to the First Line concept, making India the first market in APAC region to incorporate this standard.
In India, Datwyler’s core business consists of container closures. Manufacturing close to four billion components for vials, pre-filled syringes, and diagnostic devices per year, the Pune facility plays an increasingly strategic role for the company.
The company provides a unique range of future-proof health care sealing solutions and services for primary and secondary packaging. This includes the most advanced elastomer formulations, proprietary coatings, sterilization options, and aluminium seals for high-efficiency production lines, to meet the demands of current pharma trends.
Datwyler’s First Line manufacturing concept for high-quality elastomer components is based on ultra-modern cleanroom technology, automated production cells, fully automated camera inspection, and a unique validated washing process. This innovative approach to manufacturing exceeds the most stringent quality standards of the European and US regulatory authorities and is certified to ISO 15378.